Rahko, a London-based startup, has just announced a new 3-year collaboration with the science and technology company Merck.
The collaboration is focused on exploring and leveraging the potential for quantum inspired machine learning to enable the discovery and development of novel drugs, molecules and materials – faster, and with greater efficiency and precision than what is currently possible.
Rahko is building the capability to better model the behavior of drugs, chemical reactions and the design of advanced materials with greater speed and accuracy than current state-of-the-art technologies. With its ambition to ‘Solve Chemistry’, Rahko brings together a multidisciplinary team of experts in machine learning, quantum chemistry and quantum computing, to solve some of the world’s most complex problems.
